Ensign Peak Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.6M | Hold |
|
|||||
|
2025
Q1 | $16M | Buy |
|
|||||
|
2024
Q4 | $10.9M | Buy |
|
|||||
|
2024
Q3 | $3.34M | Sell |
|
|||||
|
2024
Q2 | $23.4M | Sell |
|
|||||
|
2024
Q1 | $24.6M | Buy |
|
|||||
|
2023
Q4 | $14.2M | Buy |
|
|||||
|
2023
Q3 | $7.45M | Buy |
|
|||||
|
2023
Q2 | $9.52M | Buy |
|
|||||
|
2023
Q1 | $6.73M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $298K | Sell |
|
|||||
|
2022
Q2 | $937K | Buy |
|
|||||
|
2022
Q1 | $153K | Hold |
|
|||||
|
2021
Q4 | $132K | Buy |
|